Last reviewed · How we verify
IPV SSI — Competitive Intelligence Brief
phase 3
Inactivated viral vaccine
Poliovirus serotypes 1, 2, and 3
Immunology / Infectious Disease
Biologic
Live · refreshed every 30 min
Target snapshot
IPV SSI (IPV SSI) — Statens Serum Institut. IPV SSI is an inactivated poliovirus vaccine that stimulates the immune system to produce antibodies against all three poliovirus serotypes.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| IPV SSI TARGET | IPV SSI | Statens Serum Institut | phase 3 | Inactivated viral vaccine | Poliovirus serotypes 1, 2, and 3 | |
| Sabin IPV | Sabin IPV | Centers for Disease Control and Prevention, China | marketed | inactivated viral vaccine | poliovirus serotypes 1, 2, and 3 | |
| fIPV (0.1mL) IM | fIPV (0.1mL) IM | Centers for Disease Control and Prevention | marketed | inactivated viral vaccine | poliovirus serotypes 1, 2, and 3 | |
| IPV-Al | IPV-Al | AJ Vaccines A/S | marketed | Inactivated viral vaccine | Poliovirus serotypes 1, 2, and 3 | |
| vaccinated with Sabin IPV | vaccinated with Sabin IPV | Zhejiang Provincial Center for Disease Control and Prevention | marketed | vaccine | poliovirus serotypes 1, 2, and 3 | |
| Sabin IPV + Sabin IPV + Sabin IPV | Sabin IPV + Sabin IPV + Sabin IPV | Zhejiang Provincial Center for Disease Control and Prevention | marketed | inactivated viral vaccine | poliovirus serotypes 1, 2, and 3 | |
| 2wIPV+1sIPV | 2wIPV+1sIPV | Sinovac Biotech Co., Ltd | marketed | Inactivated viral vaccine | Poliovirus types 1, 2, and 3 antigens |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Inactivated viral vaccine class)
- Sinovac Biotech Co., Ltd · 9 drugs in this class
- Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
- GlaxoSmithKline · 5 drugs in this class
- Valneva Austria GmbH · 4 drugs in this class
- Medical University of Vienna · 3 drugs in this class
- Centers for Disease Control and Prevention · 3 drugs in this class
- China National Biotec Group Company Limited · 2 drugs in this class
- Statens Serum Institut · 2 drugs in this class
- Institute of Medical Biology, Chinese Academy of Medical Sciences · 2 drugs in this class
- Crucell Holland BV · 2 drugs in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- IPV SSI CI watch — RSS
- IPV SSI CI watch — Atom
- IPV SSI CI watch — JSON
- IPV SSI alone — RSS
- Whole Inactivated viral vaccine class — RSS
Cite this brief
Drug Landscape (2026). IPV SSI — Competitive Intelligence Brief. https://druglandscape.com/ci/ipv-ssi. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab